Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Malignant mesenchymal tumor × Topotecan × Clear all

Sponsor

Conditions

Ovarian Neoplasms 22 Small Cell Lung Carcinoma 20 Neuroblastoma 12 Fallopian Tube Neoplasms 10 Uterine Cervical Neoplasms 8 Carcinoma, Ovarian Epithelial 7 Lung Neoplasms 5 Neoplasm Metastasis 4 Carcinoma, Non-Small-Cell Lung 4 Leukemia, Myeloid, Acute 3 Ganglioneuroblastoma 3 Brain Neoplasms 3 Sarcoma 2 Recurrence 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neoplasms 2 Gliosarcoma 2 Glioblastoma 2 Thrombocythemia, Essential 1 Sarcoma, Ewing 1 Retinoblastoma 1 Retinal Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Peritoneal Neoplasms 1 Osteosarcoma 1 Myelodysplastic-Myeloproliferative Diseases 1 Multiple Myeloma 1 Medulloblastoma 1

Interventions

Radiotherapy, Conformal 2 Ifosfamide 2 Doxorubicin 2 romidepsin 1 indolepropanol phosphate 1 etoposide phosphate 1 Watchful Waiting 1 Vincristine 1 Sunitinib 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy 1 Polymerase Chain Reaction 1 Observation 1 Neoadjuvant Therapy 1 Irinotecan 1 HhAntag691 1 Granulocyte Colony-Stimulating Factor 1 Gene Expression Profiling 1 Filgrastim 1 Etoposide 1 Dactinomycin 1 Cyclophosphamide 1 Blotting, Western 1 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡